The American Society of Nephrology (ASN) today announced the appointment of Michael Allon, MD, as the first Editor-in-Chief of Kidney360, ASN’s new online journal launching in January 2020.
Dr. Allon is a Professor of Medicine at University of Alabama at Birmingham, where he serves as the Associate Director for Clinical Affairs and the Medical Director of Dialysis Operations in the Division of Nephrology. He has a longstanding clinical research interest in dialysis and has published over 140 peer-reviewed papers on vascular access. He was the principal investigator at UAB for several multi-center clinical dialysis studies sponsored by NIDDK, including HEMO, DAC, and HFM.
Kidney360 will be a free global and peer-reviewed publication that offers original investigations, meta-analyses, and reviews of basic, translational, clinical, epidemiologic, health policy, population science, and global kidney research. Because the journal seeks to advance kidney science, it will encourage manuscript submissions that contribute to reproducibility, including those describing negative results.
ASN President Mark Rosenberg, MD, FASN, commented, “We are very pleased Dr. Allon will serve as the editor of Kidney360. Dr. Allon has decades of impressive experience in research, editing and patient care. I couldn’t think of a more qualified person for the job.”
The American Society of Nephrology (ASN) today announced the appointment of Michael Allon, MD, as the first Editor-in-Chief of Kidney360, ASN’s new online journal launching in January 2020.
Dr. Allon is a Professor of Medicine at University of Alabama at Birmingham, where he serves as the Associate Director for Clinical Affairs and the Medical Director of Dialysis Operations in the Division of Nephrology. He has a longstanding clinical research interest in dialysis and has published over 140 peer-reviewed papers on vascular access. He was the principal investigator at UAB for several multi-center clinical dialysis studies sponsored by NIDDK, including HEMO, DAC, and HFM.
Kidney360 will be a free global and peer-reviewed publication that offers original investigations, meta-analyses, and reviews of basic, translational, clinical, epidemiologic, health policy, population science, and global kidney research. Because the journal seeks to advance kidney science, it will encourage manuscript submissions that contribute to reproducibility, including those describing negative results.
ASN President Mark Rosenberg, MD, FASN, commented, “We are very pleased Dr. Allon will serve as the editor of Kidney360. Dr. Allon has decades of impressive experience in research, editing and patient care. I couldn’t think of a more qualified person for the job.”
ASN’s Publication Committee Chair Ziyad Al-Aly, MD, FASN, added, “Dr. Allon brings a wealth of research and editorial experience and great passion to Kidney360. We are highly confident that we have found an exceptional leader; through his leadership, Kidney360 will be a leader in online open access publishing of meritorious and impactful kidney research. We are thrilled to welcome Dr. Allon in this role, and I know he and his team will work tirelessly to ensure that Kidney360 does its part in helping us win the fight against kidney diseases.”
For more information on Dr. Allon and the new journal, Kidney360, please see the ASN Press Release .
Stay tuned to Kidney News Online for an interview with Dr. Allon and more information on the new journal.
© 2021 American Society of Nephrology | All Rights Reserved
Powered by: PubFactory